Join Team Cancer Research UK for the Edinburgh Half Marathon 2026 and play your part in supporting vital cancer research.

NETs and NECs are very different. So it is important to know which one you have. Talk to your doctor or specialist nurse if you are not sure. Neuroendocrine cancers start in nerve and gland cells that ...

What is the lymphatic system? The lymphatic system is a system of thin tubes and lymph nodes that run throughout the body. Lymph nodes are bean shaped glands. The thin tubes are called lymph vessels ...

The Local Stats Data Hub offers information from across the cancer pathway, providing the best available statistics for a chosen constituency.

Escape to nature and take on a 10k, half marathon or full marathon experience in the Trossachs. You’ll explore stunning lochs, waterfalls and forests, all whilst supporting life-saving research.

What is a breast ultrasound scan? The ultrasound scanner has a probe that gives off sound waves. The probe looks a bit like a microphone. The sound waves bounce off the tissues in your breast, and the ...

a test that looks for blood in your poo. This is a Faecal Immunochemical Test (FIT) looking at the whole of the inside of your large bowel using a flexible tube (colonoscopy) or to look at the lower ...

With your colleagues, you can have a fun day out helping to beat cancer, with different opportunities to choose from there is ...

What is acute lymphoblastic leukaemia (ALL)? Acute lymphoblastic leukaemia is a type of blood cancer. It starts from young white blood cells called lymphocytes in the bone marrow. Find out about ...

To achieve this, we need to fund excellent research and exceptional researchers to unlock new and better ways to prevent, diagnose and treat cancer. That includes supporting high-quality research that ...

The nasopharynx connects the back of your nose to the back of your mouth. Cancer that develops in the nasopharynx is called nasopharyngeal cancer. Nasopharyngeal cancer can cause symptoms. For example ...

This trial is looking at a new drug called divarasib for non small cell lung cancer that has got worse after treatment.